1. Teledermatology

   • John D. Whited

   Leading Article 22 August 2012 Pages: 59 - 64

   

2. The Impact of COLIPA Guidelines for Assessment of Skin Compatibility on the Development of Cosmetic Products

   • Marisa Meloni
   • Enzo Berardesca

   Current Opinion 22 August 2012 Pages: 65 - 68

   

3. Cutaneous Reactions to Anticoagulants

   • Job Harenberg
   • Ursula Hoffmann
   • Christiane Bayerl

   Therapy in Practice 22 August 2012 Pages: 69 - 75

   

4. Phase III Vehicle-Controlled, Multi-Centered Study of Topical Alitretinoin Gel 0.1% in Cutaneous AIDS-Related Kaposi’s Sarcoma

   • Neil J. Bodsworth
   • Mark Bloch
   • The International Panretin® Gel KS Study Group

   Original Research Article 22 August 2012 Pages: 77 - 87

   

5. Clobetasol Propionate Foam, 0.05%

   • Ezequiel Balmori Melian
   • Caroline M. Spencer
   • Blair Jarvis

   Adis New Drug Profile 22 August 2012 Pages: 89 - 92

   

6. Clobetasol Propionate Foam, 0.05%

   • Mark Lebwohl
   • Amy Krupnick

   Adis New Drug Profile 22 August 2012 Pages: 93 - 93

7. Clobetasol Propionate Foam, 0.05%

   • H. Irving Katz

   Adis New Drug Profile 22 August 2012 Pages: 93 - 93

8. Calcipotriol Ointment

   • Lesley J. Scott
   • Christopher J. Dunn
   • Karen L. Goa

   Adis Drug Evaluation 22 August 2012 Pages: 95 - 120

   

9. Cutaneous Drug Reaction Case Reports

   Pharmacovigilance 22 August 2012 Pages: 121 - 127

10. ‘Wonder Drugs’ for Psoriasis

    • Ulrich Mrowietz

    Correspondence 22 August 2012 Pages: 129 - 130